Pei Wang, Xing-chang Ren, Jin Yu, Yi Lin, Xi-ming Wu
Index: Yao Xue Xue Bao 39(10) , 782-6, (2004)
Full Text: HTML
To study the therapeutic effects of N,N'-diacetyl-L-cystine (DiNAC) on immunological liver failure.Serum ALT, AST and T cell subsets in peripheral blood of the experimental animals during the trial period were analyzed by an automatic serum analyzer and a flow cytometer, respectively. The sectioned liver specimens were examined under a light microscope. And 24 h after the injection of Gal/LPS, the survival rate of rats was calculated.DiNAC (50, 200, 800 mg x kg(-1), i.p.) suppressed the elevation of serum levels of ALT and AST, markedly enhanced proliferation and differentiation of T cell subsets (CD4+, CD8+ and Th1, Th2), and improved all the histopathological features. In mice of fulminant hepatic failure (FHF), the survival time significantly prolonged and the survival rate increased 24 h after i.p. DiNAC. These effects were obviously dose-dependent.DiNAC on mice with FHF has an inhibitory action which is related to immune mechanism.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
N,N'-Diacetyl-L-cystine
CAS:5545-17-5 |
C10H16N2O6S2 |
Immunomodulation with DiNAC-- a new approach to the treatmen...
2002-05-01 [Expert Opin. Investig. Drugs 11(5) , 717-20, (2002)] |
The new oral immunomodulating drug DiNAC induces brachial ar...
2008-01-01 [Atherosclerosis 196(1) , 275-82, (2008)] |
N,N'-Diacetyl-L-cystine-the disulfide dimer of N-acetylcyste...
1999-03-01 [J. Pharmacol. Exp. Ther. 288(3) , 1174-84, (1999)] |
Monitoring of the subtraction process in solid-phase represe...
2001-06-27 [Gene 271(2) , 183-92, (2001)] |
[Cysteine in parenteral nutrition: comparative study of N-ac...
1988-04-01 [Infusionstherapie 15(2) , 89-92, (1988)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved